Diagnosis and manifestations of chronic graft-versus-host disease

References 

1. In:  Sullivan KM,  Blume KG,  Forman SJ,  Appelbaum FR editor. Thomas' Hematopoietic Cell Transplantation. 3rd ed.. Malden, MA: Blackwell Publishing; 2004;p. 635–664
2. Kim DH, Jund HD, Lee NY, et al. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and it's severity after allogeneic transplantation. Transplantation. 2007;84:397–404
3. Shimada M, Onizuka M, Machida S, et al. Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease. British Journal of Haematology. 2007;139:458–463
4. Sarantopoulos S, Stevenson KE, Kim HT, et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clinical Cancer Research. 2007;15:6107–6114
5. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458–1466
   • MEDLINE
   • CrossRef
6. Wysoczanska B, Bogunia-Kubik K, Dlubek D, et al. Association with the presence of naïve T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse. Transplant Proceedings. 2007;39:2898–2901
7. Dutt S, Tseng D, Ermann J, et al. Naïve and memory T cells induce different types of graft-versus-host disease. Journal of Immunology. 2007;179:6547–6554
8. Przybylski GK, Kreuzer KA, Siegert W, et al. No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GVHD. Journal of Applied Genetics. 2007;48:397–404
9. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology. 1991;28:250–259
   • MEDLINE
10. Przepiorka D, Anderlini P, Saliba R, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 2001;98:1695–1700
    • MEDLINE
    • CrossRef
11. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 2002;100:406–414
    • MEDLINE
    • CrossRef
12. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft vs. host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine. 1980;69:204–217
13. Kollman C, Howe CWS, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051
    • MEDLINE
    • CrossRef
14. Cutler C, Giri S, Jeyapalan S, et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. Journal of Clinical Oncology. 2001;19:3685–3691
15. Mielcarek M, Martin PJ, Leisenring , et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 2003;102:756–762
    • MEDLINE
    • CrossRef
16. Flowers MED, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100:415–419
    • MEDLINE
    • CrossRef
17. Eapen M, Logan BR, Confer DL, et al. Peripheal blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biology of Blood and Marrow Transplantation. 2007;13:1461–1468
18. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosos and Staging Working Group Report. Biology of Blood and Marrow Transplantation. 2005;11:945–955